Natural products against inflammation and atherosclerosis: Targeting on gut microbiota

The gut microbiota (GM) has become recognized as a crucial element in preserving human fitness and influencing disease consequences. Commensal and pathogenic gut microorganisms are correlated with pathological progress in atherosclerosis (AS). GM may thus be a promising therapeutic target for AS. Na...

Full description

Bibliographic Details
Main Authors: Bing Deng, Liyu Tao, Yiru Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-12-01
Series:Frontiers in Microbiology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fmicb.2022.997056/full
_version_ 1797987943309115392
author Bing Deng
Liyu Tao
Yiru Wang
author_facet Bing Deng
Liyu Tao
Yiru Wang
author_sort Bing Deng
collection DOAJ
description The gut microbiota (GM) has become recognized as a crucial element in preserving human fitness and influencing disease consequences. Commensal and pathogenic gut microorganisms are correlated with pathological progress in atherosclerosis (AS). GM may thus be a promising therapeutic target for AS. Natural products with cardioprotective qualities might improve the inflammation of AS by modulating the GM ecosystem, opening new avenues for researches and therapies. However, it is unclear what components of natural products are useful and what the actual mechanisms are. In this review, we have summarized the natural products relieving inflammation of AS by regulating the GM balance and active metabolites produced by GM.
first_indexed 2024-04-11T07:54:56Z
format Article
id doaj.art-a4018663149248f7ace934ee875bd45f
institution Directory Open Access Journal
issn 1664-302X
language English
last_indexed 2024-04-11T07:54:56Z
publishDate 2022-12-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Microbiology
spelling doaj.art-a4018663149248f7ace934ee875bd45f2022-12-22T04:35:57ZengFrontiers Media S.A.Frontiers in Microbiology1664-302X2022-12-011310.3389/fmicb.2022.997056997056Natural products against inflammation and atherosclerosis: Targeting on gut microbiotaBing Deng0Liyu Tao1Yiru Wang2Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, ChinaShuguang Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, ChinaLonghua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, ChinaThe gut microbiota (GM) has become recognized as a crucial element in preserving human fitness and influencing disease consequences. Commensal and pathogenic gut microorganisms are correlated with pathological progress in atherosclerosis (AS). GM may thus be a promising therapeutic target for AS. Natural products with cardioprotective qualities might improve the inflammation of AS by modulating the GM ecosystem, opening new avenues for researches and therapies. However, it is unclear what components of natural products are useful and what the actual mechanisms are. In this review, we have summarized the natural products relieving inflammation of AS by regulating the GM balance and active metabolites produced by GM.https://www.frontiersin.org/articles/10.3389/fmicb.2022.997056/fullgut microbiotaatherosclerosisinflammationnatural productsimmune
spellingShingle Bing Deng
Liyu Tao
Yiru Wang
Natural products against inflammation and atherosclerosis: Targeting on gut microbiota
Frontiers in Microbiology
gut microbiota
atherosclerosis
inflammation
natural products
immune
title Natural products against inflammation and atherosclerosis: Targeting on gut microbiota
title_full Natural products against inflammation and atherosclerosis: Targeting on gut microbiota
title_fullStr Natural products against inflammation and atherosclerosis: Targeting on gut microbiota
title_full_unstemmed Natural products against inflammation and atherosclerosis: Targeting on gut microbiota
title_short Natural products against inflammation and atherosclerosis: Targeting on gut microbiota
title_sort natural products against inflammation and atherosclerosis targeting on gut microbiota
topic gut microbiota
atherosclerosis
inflammation
natural products
immune
url https://www.frontiersin.org/articles/10.3389/fmicb.2022.997056/full
work_keys_str_mv AT bingdeng naturalproductsagainstinflammationandatherosclerosistargetingongutmicrobiota
AT liyutao naturalproductsagainstinflammationandatherosclerosistargetingongutmicrobiota
AT yiruwang naturalproductsagainstinflammationandatherosclerosistargetingongutmicrobiota